Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
AEs, anemia, announced, antiangiogenic, Arkin, atezolizumab, axitinib, Bayer, Berger, Bernstein, blended, Bristol, cabozantinib, cetuximab, CFO, CMS, commonplace, complaint, confirmatory, construction, corruption, counsel, County, cut, Cybersecurity, daily, Dale, dataset, declaratory, display, District, dominant, driver, duty, enrichment, Fast, fiduciary, Fifty, Flatiron, fulfilled, gBRCA, Genentech, Grossman, harboring, HBr, Helena, hemoglobin, immunotherapy, Imputation, inclusive, indirect, inter, Jamie, Keytruda, Kimbro, landlord, lawsuit, lengthier, lenvatinib, Lindsey, Litowitz, marker, Mateo, McCall, Medina, Medivation, memorandum, Merck, misleading, mismanagement, misrepresentation, modification, monoclonal, Moran, motion, Northern, notable, ODAC, Opdivo, osimertinib, Parkway, pazopanib, Pension, physical, plaintiff, pooled, pose, prejudice, prostate, purported, QTc, qualification, Ralph, rarity, reaction, reclassification, reclassified, region, resign, resigned, Rocco, Rolfe, Sanchez, sBRCA, serve, shareholder, simplify, Simplifying, software, Sonny, sorafenib, Squibb, Steve, substitute, Subtopic, successor, sunitinib, Tagrisso, TagrissoTM, teaching, Tenant, unjust, unspecified, user, vigorously, Welfare, Yu
Removed:
biomarin, closedown, cysteine, dacomitinib, depreciate, discontinuation, escalation, expanding, explanation, extremely, gemcitabine, hired, inactivate, inhibitory, intestine, irreversibly, location, nonvested, North, pancreatic, permanently, pipeline, rash, recommended, residue, skin, succumb, tolerate, unvested
Filing tables
Filing exhibits
Related press release
CLVSQ similar filings
Filing view
External links
Exhibit 21.1
List of Subsidiaries of Clovis Oncology, Inc.
Name: |
| Jurisdiction of Organization: |
|
Clovis Oncology UK Limited |
| United Kingdom |
|
Clovis Oncology Italy S.r.l. |
| Italy |
|
Clovis Oncology Switzerland GmbH |
| Switzerland |
|
Clovis Oncology France SAS |
| France |
|
Clovis Oncology Germany GmbH |
| Germany |
|